Zoetis Inc. (NYSE:ZTS) Shares Sold by Jackson Hole Capital Partners LLC

Jackson Hole Capital Partners LLC trimmed its holdings in Zoetis Inc. (NYSE:ZTS) by 10.4% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,717 shares of the company’s stock after selling 2,168 shares during the period. Jackson Hole Capital Partners LLC’s holdings in Zoetis were worth $3,050,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of ZTS. Mizuho Securities USA LLC raised its position in shares of Zoetis by 13,726.9% in the third quarter. Mizuho Securities USA LLC now owns 4,865,000 shares of the company’s stock valued at $950,524,000 after buying an additional 4,829,815 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Zoetis in the fourth quarter valued at about $196,651,000. Amundi raised its position in shares of Zoetis by 46.2% in the fourth quarter. Amundi now owns 2,748,719 shares of the company’s stock valued at $453,355,000 after buying an additional 867,993 shares during the last quarter. Assenagon Asset Management S.A. raised its position in shares of Zoetis by 296.9% in the fourth quarter. Assenagon Asset Management S.A. now owns 889,444 shares of the company’s stock valued at $144,917,000 after buying an additional 665,331 shares during the last quarter. Finally, Nordea Investment Management AB raised its position in shares of Zoetis by 38.3% in the fourth quarter. Nordea Investment Management AB now owns 2,065,514 shares of the company’s stock valued at $336,266,000 after buying an additional 572,511 shares during the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have commented on ZTS shares. Piper Sandler lifted their target price on shares of Zoetis from $200.00 to $205.00 and gave the stock an “overweight” rating in a research note on Thursday, February 27th. Stifel Nicolaus reduced their target price on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research note on Tuesday, January 7th. UBS Group started coverage on shares of Zoetis in a research note on Monday, December 9th. They set a “neutral” rating and a $196.00 target price on the stock. Morgan Stanley reduced their target price on shares of Zoetis from $243.00 to $238.00 and set an “overweight” rating on the stock in a research note on Friday, February 14th. Finally, StockNews.com upgraded shares of Zoetis from a “hold” rating to a “buy” rating in a research report on Friday. One analyst has rated the stock with a hold rating, ten have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $215.90.

Zoetis Trading Up 1.8 %

Shares of ZTS stock opened at $170.34 on Friday. The company has a debt-to-equity ratio of 1.09, a quick ratio of 1.08 and a current ratio of 1.75. The stock has a market capitalization of $76.28 billion, a P/E ratio of 31.14, a price-to-earnings-growth ratio of 2.78 and a beta of 0.94. The company has a 50 day moving average price of $166.72 and a 200 day moving average price of $176.78. Zoetis Inc. has a fifty-two week low of $144.80 and a fifty-two week high of $200.33.

Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Thursday, February 13th. The company reported $1.40 EPS for the quarter, topping the consensus estimate of $1.37 by $0.03. Zoetis had a net margin of 26.86% and a return on equity of 53.82%. The company had revenue of $2.32 billion during the quarter, compared to analysts’ expectations of $2.30 billion. Equities research analysts predict that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 3rd. Shareholders of record on Monday, April 21st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.17%. The ex-dividend date of this dividend is Monday, April 21st. Zoetis’s dividend payout ratio (DPR) is presently 36.56%.

Insiders Place Their Bets

In other Zoetis news, EVP Roxanne Lagano sold 326 shares of the business’s stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $171.18, for a total transaction of $55,804.68. Following the completion of the transaction, the executive vice president now owns 16,107 shares in the company, valued at $2,757,196.26. The trade was a 1.98 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.16% of the stock is currently owned by company insiders.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.